The recent Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda has been declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO), marking a critical juncture in global health. This declaration, reserved for events with demonstrated cross-border potential, underscores the severity and urgency of the situation. As of May 26, 2026, over 1,200 suspected or confirmed cases and 238 deaths have been reported, with the true number of infections likely much higher. The Bundibugyo virus, the strain causing this outbreak, is distinct from the Zaire ebolavirus, and the lack of cross-protection means that the response is heavily reliant on traditional containment measures, including case isolation, contact tracing, and safe burials.
The WHO's assessment of the risk is stark: very high at the national level in DRC and Uganda, high at the regional level, and low at the global level. However, the ongoing undetected transmission for several weeks before laboratory confirmation highlights the complexity and challenge of the outbreak. National health authorities across multiple regions have activated their response systems, with Africa CDC taking a central coordinating role, and the WHO and Africa CDC forming a continental Incident Management Support Team to address the crisis.
In the Americas, the Pan American Health Organization (PAHO) has advised countries to strengthen preparedness, while the UK Health Security Agency (UKHSA) has confirmed a low risk to the UK population, with the NHS implementing safe procedures and specialist centers. The European Centre for Disease Prevention and Control (ECDC) continues to monitor the situation, emphasizing the very low risk for the general population in Europe.
For employers, the situation is a critical operational and duty-of-care matter. The immediate challenge is the risk of employees becoming stranded due to travel restrictions imposed by multiple governments. The 21-day incubation monitoring window adds complexity, as employees who have recently departed the region remain under ongoing monitoring obligations. UK-based organizations, in particular, should register with the UKHSA's Returning Workers Scheme and monitor government updates.
Employers are urged to reactivate their pandemic or health security committees, engage travel risk management providers, and comply with national government travel advisories. A 21-day return monitoring protocol is essential, with clear communication on symptom recognition and escalation pathways. In-region workers should be registered with national schemes, and managers should be briefed on recognition and escalation procedures.
Furthermore, organizations with operations in the eastern DRC should review business continuity plans, assess exposure, and engage in-country partners to identify operational alternatives. The outbreak's rapid spread across provinces in a densely connected trade corridor underscores the need for proactive measures.
In conclusion, the Ebola outbreak in the DRC and Uganda is a high-consequence event with no available vaccine. Governments and employers must treat it as an active operational and duty-of-care matter, avoiding travel to the affected region, monitoring returning workers rigorously, and complying with national advisory frameworks. The outcome of this crisis will depend on swift, coordinated action and a comprehensive understanding of the evolving situation.
